Search results
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial By Investing.com
Investing.com· 1 day agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
Could a bird flu pandemic spread to humans?
Al Jazeera· 6 days agoThe bird flu virus, which was first reported in US poultry farms in 14 states in early 2022, has spread to cows and two humans in the first-ever cases of...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 1 day agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
Return of masks & 3-week isolation for schoolkids amid whooping cough outbreak
The US Sun· 3 days agoGP SURGERIES are asking patients to wear masks while infected schoolkids will need to isolate for...
NanoViricides Has Filed its Quarterly Report
The Sacramento Bee· 1 day agoSHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that ...
National Institutes of Health (NIH) to Open Long COVID Clinical Trials to Study Sleep Disturbances,...
Sierra Sun Times· 6 days agoThe mid-stage trials, part of NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative, will...enrolling participants across the United States testing treatments to ...
Richard Feldman column: COVID is not gone; proceed with caution
The Herald Bulletin· 2 days agoThere’s an expression, “You may be done with COVID, but COVID isn’t done with you.” The situation...
Chicago health officials warn of uptick in invasive meningococcal disease
CBS News· 1 day agoThe Chicago Department of Public Health has issued a new warning, following a local uptick in...
NanoViricides unveils new data showing lead drug asset’s strong activity against RSV
Proactive Investors· 2 days agoThe study compared extended dosing of NV-387 with a high dose of ribavirin, the only currently...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Morningstar· 6 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces ...
